Cover Image

Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma

Abstract Like other monoclonal antibodies, immune checkpoint inhibitors may be immunogenic in some patients, potentially affecting pharmacokinetics (PKs) and clinical outcomes. In post hoc analyses, we characterized antidrug antibody (ADA) development with avelumab monotherapy in patients with metas...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ping Hu (Author), Haiqing Isaac Dai (Author), James Bourdage (Author), Dongli Zhou (Author), Ky Trang (Author), Karey Kowalski (Author), Carlo Bello (Author), Jennifer Hibma (Author), Akash Khandelwal (Author), Kyra Cowan (Author), Jennifer Dong (Author), Karthik Venkatakrishnan (Author), Wei Gao (Author)
Format:	Book
Published:	Wiley, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma
by: Justin J. Wilkins, et al.
Published: (2019)

Case-control matching‐guided exposure‐efficacy relationship for avelumab in patients with urothelial carcinoma
by: Pooneh Soltantabar, et al.
Published: (2023)

Re-induction of avelumab for patients with metastatic merkel cell carcinoma
by: Goto Hiroyuki, et al.
Published: (2023)

Merkel cell carcinoma in the context of follicular lymphoma treated with radiation and avelumab
by: Aya Nishizawa, MD, PhD, et al.
Published: (2024)

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
by: Bharmal M, et al.
Published: (2019)

Model‐informed drug development supporting the approval of the avelumab flat‐dose regimen in patients with advanced renal cell carcinoma
by: Joanna C. Masters, et al.
Published: (2022)

Recurrence of metastatic Merkel carcinoma after cessation of avelumab in a patient previously with a complete response
by: Alexandra Picard‐Gauci, et al.
Published: (2022)

Successful rechallenge with avelumab in a patient with advanced Merkel cell carcinoma who presented pembrolizumab‐induced myositis
by: Clémence Bertold, et al.
Published: (2023)

Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab
by: Nadia Terranova, et al.
Published: (2022)

Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma
by: Qian Xie, et al.
Published: (2022)

Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
by: Qian Xie, et al.
Published: (2022)

Merkel cell carcinoma
by: K. Mistry, et al.
Published: (2021)

A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma
by: Tiako Meyo M, et al.
Published: (2022)

Metastatic urothelial carcinoma
by: Elisabeth Gómez-Moyano, et al.
Published: (2021)

Avelumab-Induced Scleroderma in a Patient with Metastatic Squamous Cell Carcinoma of the Lung
by: Jeffrey L. Dobrzynski, et al.
Published: (2022)

Merkel cell carcinoma of the abdominal wall
by: Vandana L Gaopande, et al.
Published: (2015)

Merkel cell carcinoma in an immunosuppressed patient
by: Heliana Freitas de Oliveira Góes, et al.
Published: (2017)

Plasmacytoid urothelial carcinoma of the bladder
by: Meihua Qin, et al.
Published: (2014)

The Biological and Clinical Aspects of Merkel Cell Carcinoma
Published: (2023)

Merkel Cell Carcinoma in Kidney Transplant Recipients
by: Henry H. L. Wu, et al.
Published: (2023)

Merkel cell carcinoma associated with tofacitinib therapy
by: Luke S. Wallis, MD, et al.
Published: (2021)

Merkel Cell Carcinoma on the Face: Case Report
by: Shaikha Salah Alhaj, et al.
Published: (2024)

Secondary Merkel Cell Carcinoma Manifested in the Parotid
by: M. Basati, et al.
Published: (2013)

Merkel Cell Carcinoma With Isolated Pancreatic Metastasis
by: Prasanth Lingamaneni MD, et al.
Published: (2021)

Acquired Hemophilia A and urothelial carcinoma
by: Fadi Taza, et al.
Published: (2021)

Unusual manifestations of secondary urothelial carcinoma
by: Chaohui Lisa Zhao, et al.
Published: (2016)

Immunohistochemical and molecular markers in urothelial carcinoma
by: Ranjan Agrawal
Published: (2017)

Role of FGFR3 in Urothelial Carcinoma
by: Malik Akanksha, et al.
Published: (2019)

Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma
by: Woo Jin Oh, et al.
Published: (2016)

Advances in Immunology: A Cornerstone in Diagnosis and Therapy of Merkel Cell Carcinoma
by: Wyatt Lydolph MD, et al.
Published: (2022)

Merkel cell carcinoma versus metastatic small cell primary bronchogenic carcinoma
by: Katya Lisette Velasquez Cantillo, et al.
Published: (2013)

Advanced Merkel cell carcinoma in setting of pembrolizumab therapy for squamous cell carcinoma
by: Henry Jeon, BSc, et al.
Published: (2024)

Merkel cell carcinoma in a young female on infliximab
by: Alex Harrison, DO, et al.
Published: (2022)

Metachronous Merkel Cell Carcinoma: A Case Report
by: Jondavid Pollock, et al.
Published: (2011)

Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies
by: Alessia Villani, et al.
Published: (2019)

Merkel cell carcinoma in an immunocompetent male statin user,
by: Isaura Azevedo Fasciani, et al.
Published: (2020)

Merkel Cell Carcinoma: Mind The Genital Metastatic Sites!
by: Giacomo Santandrea, et al.
Published: (2023)

Concomitant chronic lymphocytic leukemia and Merkel cell carcinoma
by: Darko Antic, et al.
Published: (2015)

Malignant melanoma after treatment for Merkel cell carcinoma,
by: Masato Ishikawa, et al.
Published: (2020)

A Lesion Surrounded by the Rainbow: Merkel Cell Carcinoma
by: Melek Aslan Kayıran, et al.
Published: (2024)